Authors: | Kopetz, S.; Yoshino, T.; Kim, T. W.; Wasan, H. S.; Van Cutsem, E.; Ciardiello, F.; Maughan, T. S.; Eng, C.; Yaeger, R.; Desai, J.; Zhang, X.; Usari, T.; Mori, A.; Tabernero, J. |
Abstract Title: | BREAKWATER: An open-label, multicenter, randomized, phase 3 study, with a safety lead-in (SLI), of first-line (1L) encorafenib (E) + cetuximab (C) ± chemotherapy (CT) vs standard-of-care (SOC) CT for BRAF V600E-mutant metastatic colorectal cancer (mCRC) |
Meeting Title: | 2023 ASCO Annual Meeting |
Journal Title: | Journal of Clinical Oncology |
Volume: | 41 |
Issue: | 16 Suppl. |
Meeting Dates: | 2023 Jun 2-6 |
Meeting Location: | Chicago, IL |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2023-06-01 |
Language: | English |
DOI: | 10.1200/JCO.2023.41.16_suppl.TPS3627 |
PROVIDER: | EBSCOhost |
PROVIDER: | cinahl |
DOI/URL: | |
Notes: | Meeting Abstract: TPS3627 -- Meeting was also available virtually -- Source: Cinahl |